Michael Karin

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 24

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Cancer prevention research (Philadelphia, Pa.)

Nature

Science advances

University of California San Diego

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of California San Diego

United States

Distinguished Professor :: Pharmacology

Publications

Laura Antonucci, Michael Karin
The Past and Future of Inflammation as a Target to Cancer Prevention. Cancer prevention research (Philadelphia, Pa.) (2024)
Laura Antonucci, Michael Karin
The Past and Future of Inflammation as a Target to Cancer Prevention. Cancer prevention research (Philadelphia, Pa.) 17 (4) (2024)
Laura Antonucci, Michael Karin
The Past and Future of Inflammation as a Target to Cancer Prevention. Cancer prevention research (Philadelphia, Pa.) 17 (4) (2024)
Laura Antonucci, Michael Karin
The Past and Future of Inflammation as a Target to Cancer Prevention. Cancer prevention research (Philadelphia, Pa.) (2024)
Laura Antonucci, Michael Karin
The Past and Future of Inflammation as a Target to Cancer Prevention. Cancer prevention research (Philadelphia, Pa.) (2024)
Laura Antonucci, Michael Karin
The Past and Future of Inflammation as a Target to Cancer Prevention. Cancer prevention research (Philadelphia, Pa.) 17 (4) (2024)
Laura Antonucci, Michael Karin
The Past and Future of Inflammation as a Target to Cancer Prevention. Cancer prevention research (Philadelphia, Pa.) (2024)
Michael Karin, Ju Youn Kim
MASH as an emerging cause of hepatocellular carcinoma: current knowledge and future perspectives. Molecular oncology (2024)
Alexandra Rundberg Nilsson, Hongxu Xian, Shabnam Shalapour, Jörg Cammenga, Michael Karin
IRF1 regulates self-renewal and stress responsiveness to support hematopoietic stem cell maintenance. Science advances 9 (43) (2023)
Li Gu, Yahui Zhu, Maiya Lee, Albert Nguyen, Nicolas T Ryujin, Jian Yu Huang, Shusil K Pandit, Shadi Chamseddine, Lianchun Xiao, Yehia I Mohamed, Ahmed O Kaseb, Michael Karin, Shabnam Shalapour
Angiotensin II receptor inhibition ameliorates liver fibrosis and enhances hepatocellular carcinoma infiltration by effector T cells. Proceedings of the National Academy of Sciences of the United States of America 120 (19) (2023)
Li Gu, Yahui Zhu, Maiya Lee, Albert Nguyen, Nicolas T Ryujin, Jian Yu Huang, Shusil K Pandit, Shadi Chamseddine, Lianchun Xiao, Yehia I Mohamed, Ahmed O Kaseb, Michael Karin, Shabnam Shalapour
Angiotensin II receptor inhibition ameliorates liver fibrosis and enhances hepatocellular carcinoma infiltration by effector T cells. Proceedings of the National Academy of Sciences of the United States of America 120 (19) (2023)
Li Gu, Yahui Zhu, Maiya Lee, Albert Nguyen, Nicolas T Ryujin, Jian Yu Huang, Shusil K Pandit, Shadi Chamseddine, Lianchun Xiao, Yehia I Mohamed, Ahmed O Kaseb, Michael Karin, Shabnam Shalapour
Angiotensin II receptor inhibition ameliorates liver fibrosis and enhances hepatocellular carcinoma infiltration by effector T cells. Proceedings of the National Academy of Sciences of the United States of America 120 (19) (2023)
Youjun Li, Michael Karin, Edward V Prochownik
Cholesterol esterification and p53-mediated tumor suppression. Exploration of targeted anti-tumor therapy 4 (5) (2023)
Li Gu, Yahui Zhu, Maiya Lee, Albert Nguyen, Nicolas T Ryujin, Jian Yu Huang, Shusil K Pandit, Shadi Chamseddine, Lianchun Xiao, Yehia I Mohamed, Ahmed O Kaseb, Michael Karin, Shabnam Shalapour
Angiotensin II receptor inhibition ameliorates liver fibrosis and enhances hepatocellular carcinoma infiltration by effector T cells. Proceedings of the National Academy of Sciences of the United States of America 120 (19) (2023)
Li Gu, Yahui Zhu, Maiya Lee, Albert Nguyen, Nicolas T Ryujin, Jian Yu Huang, Shusil K Pandit, Shadi Chamseddine, Lianchun Xiao, Yehia I Mohamed, Ahmed O Kaseb, Michael Karin, Shabnam Shalapour
Angiotensin II receptor inhibition ameliorates liver fibrosis and enhances hepatocellular carcinoma infiltration by effector T cells. Proceedings of the National Academy of Sciences of the United States of America 120 (19) (2023)
Hua Su, Fei Yang, Rao Fu, Brittney Trinh, Nina Sun, Junlai Liu, Avi Kumar, Jacopo Baglieri, Jeremy Siruno, Michelle Le, Yuhan Li, Stephen Dozier, Bindu Nair, Aveline Filliol, Nachanok Sinchai, Sara Brin Rosenthal, Jennifer Santini, Christian M Metallo, Anthony Molina, Robert F Schwabe, Andrew M Lowy, David Brenner, Beicheng Sun, Michael Karin
Publisher Correction: Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome. Nature (2023)
Li Gu, Yahui Zhu, Maiya Lee, Albert Nguyen, Nicolas T Ryujin, Jian Yu Huang, Shusil K Pandit, Shadi Chamseddine, Lianchun Xiao, Yehia I Mohamed, Ahmed O Kaseb, Michael Karin, Shabnam Shalapour
Angiotensin II receptor inhibition ameliorates liver fibrosis and enhances hepatocellular carcinoma infiltration by effector T cells. Proceedings of the National Academy of Sciences of the United States of America 120 (19) (2023)
Na-Young Song, Xin Li, Buyong Ma, Jami Willette-Brown, Feng Zhu, Chengfei Jiang, Ling Su, Jyoti Shetty, Yongmei Zhao, Gongping Shi, Sayantan Banerjee, Xiaolin Wu, Bao Tran, Ruth Nussinov, Michael Karin, Yinling Hu
IKKα-deficient lung adenocarcinomas generate an immunosuppressive microenvironment by overproducing Treg-inducing cytokines. Proceedings of the National Academy of Sciences of the United States of America 119 (6) (2022)
Hua Su, Fei Yang, Rao Fu, Brittney Trinh, Nina Sun, Junlai Liu, Avi Kumar, Jacopo Baglieri, Jeremy Siruno, Michelle Le, Yuhan Li, Stephen Dozier, Bindu Nair, Aveline Filliol, Nachanok Sinchai, Sara Brin Rosenthal, Jennifer Santini, Christian M Metallo, Anthony Molina, Robert F Schwabe, Andrew M Lowy, David Brenner, Beicheng Sun, Michael Karin
Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome. Nature 610 (7931) (2022)
Dorit Trudler, Kristopher L Nazor, Yvonne S Eisele, Titas Grabauskas, Nima Dolatabadi, James Parker, Abdullah Sultan, Zhenyu Zhong, Marshall S Goodwin, Yona Levites, Todd E Golde, Jeffery W Kelly, Michael R Sierks, Nicholas J Schork, Michael Karin, Rajesh Ambasudhan, Stuart A Lipton
Soluble α-synuclein-antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia. Proceedings of the National Academy of Sciences of the United States of America 118 (15) (2021)
Yixuan Zhou, Ingmar Niels Bastian, Mark D Long, Michelle Dow, Weihua Li, Tao Liu, Rachael Katie Ngu, Laura Antonucci, Jian Yu Huang, Qui T Phung, Xi-He Zhao, Sourav Banerjee, Xue-Jia Lin, Hongxia Wang, Brian Dang, Sylvia Choi, Daniel Karin, Hua Su, Mark H Ellisman, Christina Jamieson, Marcus Bosenberg, Zhang Cheng, Johannes Haybaeck, Lukas Kenner, Kathleen M Fisch, Richard Bourgon, Genevive Hernandez, Jennie R Lill, Song Liu, Hannah Carter, Ira Mellman, Michael Karin, Shabnam Shalapour
Activation of NF-κB and p300/CBP potentiates cancer chemoimmunotherapy through induction of MHC-I antigen presentation. Proceedings of the National Academy of Sciences of the United States of America 118 (8) (2021)
Jelena Todoric, Giuseppe Di Caro, Saskia Reibe, Darren C Henstridge, Courtney R Green, Alison Vrbanac, Fatih Ceteci, Claire Conche, Reginald McNulty, Shabnam Shalapour, Koji Taniguchi, Peter J Meikle, Jeramie D Watrous, Rafael Moranchel, Mahan Najhawan, Mohit Jain, Xiao Liu, Tatiana Kisseleva, Maria T Diaz-Meco, Jorge Moscat, Rob Knight, Florian R Greten, Lester F Lau, Christian M Metallo, Mark A Febbraio, Michael Karin
Fructose stimulated de novo lipogenesis is promoted by inflammation. Nature metabolism 2 (10) (2020)
Peng Zhao, Xiaoli Sun, Cynthia Chaggan, Zhongji Liao, Kai In Wong, Feng He, Seema Singh, Rohit Loomba, Michael Karin, Joseph L Witztum, Alan R Saltiel
An AMPK-caspase-6 axis controls liver damage in nonalcoholic steatohepatitis. Science (New York, N.Y.) 367 (6478) (2020)
Mei-Fei Yueh, Feng He, Chen Chen, Catherine Vu, Anupriya Tripathi, Rob Knight, Michael Karin, Shujuan Chen, Robert H Tukey
Triclosan leads to dysregulation of the metabolic regulator FGF21 exacerbating high fat diet-induced nonalcoholic fatty liver disease. Proceedings of the National Academy of Sciences of the United States of America 117 (49) (2020)

Michael Karin.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Michael Karin